Tag Archives: First

Study sees limited risk in taking ondansetron during first trimester of pregnancy

Ondansetron (Zofran) is commonly and increasingly prescribed during pregnancy to relieve nausea. In 2014, an estimated 22 percent of pregnant women in the U.S. used the drug at some point during their pregnancy. Despite its prevalence, data on the safety of the drug and any effects on the developing fetus have been limited, with small-scale… Read More »

FDA Approves Elzonris (tagraxofusp-erzs), the First Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm and First CD123-Targeted Therapy

Print this page NEW YORK, December 21, 2018 (GLOBE NEWSWIRE) – Stemline Therapeutics, Inc. (NASDAQ:STML), a biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted approval of Elzonris (tagraxofusp-erzs; SL-401) for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)… Read More »

Samford alumnus introduces first telemedicine kiosk in an Alabama pharmacy – Yellowhammer News

As the owner of an independent pharmacy, Cole Sandlin’s goal is to make it a health care destination. “We’re located in a rural community, but I want my patients to have all of the amenities and services that bigger cities have to offer. This is what drives me to offer new things,” said Sandlin, a 2008 alumnus of Samford University’s… Read More »